Proceeds to support the advancement of lead candidate through the final stages of clinical development for recurrent C. difficile infection, and the advancement into the clinic of programs for autism spectrum disorder and chronic hepatitis B Somerville, MA, September 17, 2020 – Finch Therapeutics Group, Inc. (“Finch”), a clinical-stage microbiome drug development company, announced today[…]
On June 24, 2020, Rancher Labs (hereinafter referred to as Rancher), the creator of the most widely used Kubernetes management platform in the industry, announced that Rancher was selected as one of the best cloud solutions for WISE 2020 Enterprise Service Gold List by 36Kr, a well-known venture capital media. Rancher is the only container[…]
CP101 met the primary efficacy endpoint with statistically significant improvement in the prevention of recurrent C. difficile infection over standard of care alone in a 206-patient trial CP101 was well-tolerated with no treatment-related serious adverse events CP101 is the first oral microbiome drug to meet its primary endpoint in a pivotal trial Finch announces the[…]
These are the 2020 CNBC Disruptor 50 companies In the eighth annual Disruptor 50 list, CNBC identifies private companies whose breakthroughs are influencing business and market competition at an accelerated pace. They are poised to emerge from the coronavirus pandemic with tech platforms that have the power to dominate. The start-ups making the 2020 Disruptor list[…]
Applied BioCode (ABC-KY 6598) successfully completed the IPO on Taiwan Stock Exchange on June 9th 2020. The stock price finished at NT$ 115.5 on the first trading day, more than double its underwriting price of NT$ 48.
May 27, 2019 The outstanding core technology of niche nanomedicine, iron oxide nanoparticles developed by “MegaPro Biomedical”, a biotechnology start-up by ITRI, as well as the future nano-micelle drug carrier received the Start-up Award in the 13th National Innovation Award. After its spin-off from ITRI in 2015, the team in MegaPro Biomedical has been actively[…]
September 14, 2018 Dr. Jassy Wang will represent MegaPro Biomedical in The Third China BioMed Innovation and Investment Conference hosted by PhIRDA in Suzhou. In addition to interacting with the key pharmaceutical, new drug, and medical equipment companies as well as investment organizations in China, she will conduct a special roadshow between 4.40pm and 5[…]
San Carlos, CA, and New Haven, CT – June 14, 2018 Apexigen and Yale Cancer Center today announced a clinical trial collaboration to evaluate Apexigen’s APX005M in combination with cabiralizumab and Opdivo in patients with advanced solid tumors. The Phase 1/2 clinical trial will evaluate the safety, tolerability, and preliminary activity of APX005M in combination with cabiralizumab[…]
March 19, 2018 Quanergy Systems, Inc., the leading provider of LiDAR sensors and smart sensing solutions, today announced its selection as the recipient of the Silicon Valley Chamber of Commerce’s 2018 Murphy award for Outstanding Innovation in LiDAR Sensing Technology. Issued annually by the Silicon Valley Chamber of Commerce, the award recognizes outstanding accomplishments in[…]
November 15, 2016 Minth Group, a China-based joint venture partner of CleanWave, became the first car-parts maker to receive permission from the nation’s top economic planner to produce electric vehicles under a special scheme to encourage companies outside auto manufacturing to develop new-energy vehicles.